HealthEquity (NASDAQ:HQY) Given New $94.00 Price Target at The Goldman Sachs Group
HealthEquity (NASDAQ:HQY – Free Report) had its price objective trimmed by The Goldman Sachs Group from $107.00 to $94.00 in a report published on Thursday morning,Benzinga reports. The firm currently has a neutral rating on the stock. A number of other brokerages have also issued reports on HQY. Mizuho assumed coverage on HealthEquity in a […]
HealthEquity (NASDAQ:HQY – Free Report) had its price objective trimmed by The Goldman Sachs Group from $107.00 to $94.00 in a report published on Thursday morning,Benzinga reports. The firm currently has a neutral rating on the stock. A number of other brokerages have also issued reports on HQY. Mizuho assumed coverage on HealthEquity in a […]
